Gorlia, T.

patient tumor treatment study cancer survival trial radiotherapy glioma prognostic analysis glioblastoma anaplastic status factor group temozolomide methylation table diagnosis mutation oligodendroglioma outcome eortc progression phase necrosis grade oncol month chemotherapy research promoter fication idh 1 mutations oligodendroglial expression adjuvant mgmt promoter methylation review signi response brain anaplastic oligodendroglial tumors number toxicity tumour sample van den population department result bene fit resection chromosome feature value imatinib erlotinib university anaplastic oligodendroglioma performance status oncology disease european oligoastrocytoma assessment seizure genomic glioblastoma multiforme idh 1 presence identi pathology effect american ina expression prognostic factors model therapy